Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule

Pneumocystis jiroveci associated pneumonia (PCP) is one of the most important opportunistic conditions affecting immunocompromised patients, especially those with rheumatic diseases, often associated with lymphopenia and high serum LDH levels. The risk of PCP correlates with immunomodulators' d...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenço, Jorge, Carreira, Patricia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677122/
https://www.ncbi.nlm.nih.gov/pubmed/33251106
http://dx.doi.org/10.1016/j.rmcr.2020.101289
_version_ 1783611915297095680
author Lourenço, Jorge
Carreira, Patricia
author_facet Lourenço, Jorge
Carreira, Patricia
author_sort Lourenço, Jorge
collection PubMed
description Pneumocystis jiroveci associated pneumonia (PCP) is one of the most important opportunistic conditions affecting immunocompromised patients, especially those with rheumatic diseases, often associated with lymphopenia and high serum LDH levels. The risk of PCP correlates with immunomodulators' dosage given to control patient's underlying disease. We present a case of a PCP involving a non-lymphopenic patient with psoriatic arthritis treated with low dose of methotrexate.
format Online
Article
Text
id pubmed-7677122
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76771222020-11-27 Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule Lourenço, Jorge Carreira, Patricia Respir Med Case Rep Case Report Pneumocystis jiroveci associated pneumonia (PCP) is one of the most important opportunistic conditions affecting immunocompromised patients, especially those with rheumatic diseases, often associated with lymphopenia and high serum LDH levels. The risk of PCP correlates with immunomodulators' dosage given to control patient's underlying disease. We present a case of a PCP involving a non-lymphopenic patient with psoriatic arthritis treated with low dose of methotrexate. Elsevier 2020-11-11 /pmc/articles/PMC7677122/ /pubmed/33251106 http://dx.doi.org/10.1016/j.rmcr.2020.101289 Text en © 2020 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Lourenço, Jorge
Carreira, Patricia
Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
title Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
title_full Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
title_fullStr Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
title_full_unstemmed Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
title_short Non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: An exception to every rule
title_sort non-lymphopenic pneumocystis pneumonia in low-dose methotrexate therapy: an exception to every rule
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677122/
https://www.ncbi.nlm.nih.gov/pubmed/33251106
http://dx.doi.org/10.1016/j.rmcr.2020.101289
work_keys_str_mv AT lourencojorge nonlymphopenicpneumocystispneumoniainlowdosemethotrexatetherapyanexceptiontoeveryrule
AT carreirapatricia nonlymphopenicpneumocystispneumoniainlowdosemethotrexatetherapyanexceptiontoeveryrule

Ejemplares similares